Unitree fast-tracks Shanghai IPO targeting $6.2B valuation as embodied AI boom hits Chinese markets
The AMW Read
Unitree is a known player in humanoid robotics; the IPO update significantly advances its corporate trajectory and the segment's capital market milestone, but does not resolve an open debate.
Unitree fast-tracks Shanghai IPO targeting $6.2B valuation as embodied AI boom hits Chinese markets
Chinese humanoid robotics startup Unitree Robotics is fast-tracking its initial public offering on Shanghai's Star Market, targeting a valuation of roughly 42 billion yuan ($6.2 billion). The Shanghai Stock Exchange's listing committee will review Unitree's application on June 1, just 73 days after formal acceptance, according to an exchange filing. The company aims to raise 4.2 billion yuan by issuing at least a 10% stake, and if approved, could become the first pure-play humanoid robot company listed on the A-share market.
The accelerated timeline underscores the Chinese capital market's voracious appetite for AI hardware assets amid an embodied AI investment frenzy. Chinese embodied AI startups secured 218 investments totaling more than 57.7 billion yuan in the first five months of 2026, already surpassing total investment for all of 2025. Unitree's financials have strengthened dramatically: revenue surged to 1.17 billion yuan in the first nine months of 2025, up from 392 million yuan for full-year 2024, and gross margins reached 59.4%, with humanoid robots commanding a 62.9% margin.
The accelerated IPO signals a capital-compression arc where Chinese embodied AI startups race to public markets before commercial viability is fully proven. The segment's investment banker acknowledges that many startups still struggle with unproven business models and technical reliability issues. Unitree's humanoid segment now accounts for 51.5% of revenue, overtaking its quadruped robot business, positioning the company as a bellwether for whether the A-share market can sustain premium valuations on embodied AI hardware that remains in early commercialization stages. The 73-day fast-track approval contrasts sharply with typical Chinese IPO timelines, reflecting policy tailwinds for AI hardware listings.
